Search results
Results from the WOW.Com Content Network
Induced pluripotent stem cell taken from blood cell and converted in retinal pigment epithelium. Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). [1]
BrightFocus Foundation is a nonprofit organization based in Clarksburg, Maryland. BrightFocus funds research in an effort to discover cures for Alzheimer's disease, macular degeneration and glaucoma, and provides information and free English and Spanish resources to increase awareness about these diseases.
The Macular Society is a UK [1] [2] charity that offers support to anyone affected by central vision loss.. Many of the charity's members have age-related macular degeneration (AMD), but its services are open to people with various retinal conditions, including myopic macular degeneration, diabetic retinopathy, and inherited retinal dystrophies like Stargardt disease, Best disease, and Sorsby ...
Foundation-funded scientists at institutions throughout the world conduct research for the entire spectrum of retinal degenerative diseases including: retinitis pigmentosa, macular degeneration, Usher syndrome, Stargardt disease, Best disease, choroideremia, retinoschisis, Leber congenital amaurosis, Bardet–Biedl syndrome, cone dystrophy, cone-rod dystrophy, rod–cone dystrophy ...
Airedale NHS Foundation Trust, established 1 November 1991 as Airedale NHS Trust, [2] authorised as a foundation trust on 1 June 2010. [3]Alder Hey Children's NHS Foundation Trust, established 21 December 1990 as Royal Liverpool Children's Hospital and Community Services NHS Trust, [4] changed its name to The Royal Liverpool Children's National Health Service Trust on 15 March 1996, [5 ...
The Association of NHS Charities, operating as NHS Charities Together, is a network of over 230 charitable organisations that support the devolved National Health Service (NHS), their staff, patients, and communities in the United Kingdom. It acts as a collective voice for NHS charities, as well as coordinating national fundraising efforts.
A retinal implant is a visual prosthesis for restoration of sight to patients blinded by retinal degeneration. The system is meant to partially restore useful vision to those who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD).
This is done in the treatment of certain cancers and in age-related macular degeneration. They can involve monoclonal antibodies such as bevacizumab , antibody derivatives such as ranibizumab (Lucentis), or orally-available small molecules that inhibit the tyrosine kinases stimulated by VEGF: sunitinib , sorafenib , axitinib , and pazopanib ...